Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Porter

Showing results (631-640 of 764) with videos related to

Pageof 77
Sort By:
Arthritis Research & Therapy|May 4, 2019
Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance dataA Deodhar, P J Mease, I B McInnes, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 15, 2005
Endurance training increases skeletal muscle LKB1 and PGC-1alpha protein abundance: effects of time and intensityEric B Taylor, Jeremy D Lamb, Richard W Hurst, et al.
Mayo Clinic Proceedings|April 7, 2023
A Journey Toward Gender Equity in MedicineAlyx B Porter, Katherine H Noe, Henry D Tazelaar, et al.
British Journal of Haematology|September 13, 2014
Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemiaAli T Taher, John B Porter, Vip Viprakasit, et al.
Infection Control and Hospital Epidemiology|January 21, 2014
Prevalence of rectal colonization with multidrug-resistant Enterobacteriaceae among international patients hospitalized at Mayo Clinic, Rochester, MinnesotaShawn Vasoo, Theresa Madigan, Scott A Cunningham, et al.
Anesthesia and Analgesia|April 19, 2024
Applying a Health Equity Lens to Intraoperative Opioid Administration and Postoperative PainAdam J Milam, Mohanad R Youssef, Kenechukwu Ugochukwu, et al.
Journal of Medicinal Chemistry|March 29, 1996
Acyl-CoA:Cholesterol O-acyltransferase (ACAT) inhibitors. 2. 2-(1,3-Dioxan-2-yl)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACATP C Astles, M J Ashton, A W Bridge, et al.
Health and Quality of Life Outcomes|November 21, 2018
Patient-reported outcomes from a randomized phase II study of the deferasirox film-coated tablet in patients with transfusion-dependent anemiasAli T Taher, Raffaella Origa, Silverio Perrotta, et al.
European Journal of Haematology|January 28, 2014
Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia: the safety profile of deferasiroxAli T Taher, John B Porter, Vip Viprakasit, et al.
Plos One|September 7, 2012
The PICALM protein plays a key role in iron homeostasis and cell proliferationPaula B Scotland, Jessica L Heath, Amanda E Conway, et al.
Pageof 77

Showing results (631-640 of 764) with videos related to

Sort By:
Pageof 77
Arthritis Research & Therapy|May 4, 2019
Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance dataA Deodhar, P J Mease, I B McInnes, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 15, 2005
Endurance training increases skeletal muscle LKB1 and PGC-1alpha protein abundance: effects of time and intensityEric B Taylor, Jeremy D Lamb, Richard W Hurst, et al.
Mayo Clinic Proceedings|April 7, 2023
A Journey Toward Gender Equity in MedicineAlyx B Porter, Katherine H Noe, Henry D Tazelaar, et al.
British Journal of Haematology|September 13, 2014
Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemiaAli T Taher, John B Porter, Vip Viprakasit, et al.
Infection Control and Hospital Epidemiology|January 21, 2014
Prevalence of rectal colonization with multidrug-resistant Enterobacteriaceae among international patients hospitalized at Mayo Clinic, Rochester, MinnesotaShawn Vasoo, Theresa Madigan, Scott A Cunningham, et al.
Anesthesia and Analgesia|April 19, 2024
Applying a Health Equity Lens to Intraoperative Opioid Administration and Postoperative PainAdam J Milam, Mohanad R Youssef, Kenechukwu Ugochukwu, et al.
Journal of Medicinal Chemistry|March 29, 1996
Acyl-CoA:Cholesterol O-acyltransferase (ACAT) inhibitors. 2. 2-(1,3-Dioxan-2-yl)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACATP C Astles, M J Ashton, A W Bridge, et al.
Health and Quality of Life Outcomes|November 21, 2018
Patient-reported outcomes from a randomized phase II study of the deferasirox film-coated tablet in patients with transfusion-dependent anemiasAli T Taher, Raffaella Origa, Silverio Perrotta, et al.
European Journal of Haematology|January 28, 2014
Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia: the safety profile of deferasiroxAli T Taher, John B Porter, Vip Viprakasit, et al.
Plos One|September 7, 2012
The PICALM protein plays a key role in iron homeostasis and cell proliferationPaula B Scotland, Jessica L Heath, Amanda E Conway, et al.
Pageof 77